Non-small-molecule therapeutics for drug addiction: From pharmaco-kinetics modulating to synthetic biology
Drug addiction is a pervasive problem worldwide. It not only affects the abuser's life, but also poses a serious threat to public health. Accordingly, there is a strong demand for the development of novel and effective therapies for drug addiction. Considering that small-molecule drugs have onl...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
KeAi Communications Co. Ltd.
2024-11-01
|
| Series: | Fundamental Research |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2667325822004137 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1846148465822793728 |
|---|---|
| author | Yuanpeng Li Yibo Wang Lin Lu Jie Shi Xiaohui Wang |
| author_facet | Yuanpeng Li Yibo Wang Lin Lu Jie Shi Xiaohui Wang |
| author_sort | Yuanpeng Li |
| collection | DOAJ |
| description | Drug addiction is a pervasive problem worldwide. It not only affects the abuser's life, but also poses a serious threat to public health. Accordingly, there is a strong demand for the development of novel and effective therapies for drug addiction. Considering that small-molecule drugs have only had limited success, there is great interest in developing alternative strategies that extend the reach of small-molecule-based therapies. The antibody-based trapping approach and the enzyme catalytic strategy have been considered as promising ways to reduce the euphoria of drug users by altering drug pharmacokinetics and decreasing drug concentrations in the central nervous system. However, these biological macromolecules are generally unstable and their in vivo half-lives are short. With the rapid development of gene editing technologies, it is possible to perform ex vivo gene therapy for the long-term and stable delivery of enzymes and other effector proteins, which could free abusers from frequent injections of therapeutics. By constructing programmed gene switches that regulate spatiotemporal gene expression in response to illicit drugs, this perspective proposed the concept of preventing drug addiction by the drug itself. This strategy enables the controlled release of therapeutic proteins in vivo and is expected to improve patient safety and compliance. This will open up new opportunities for next-generation medicine and hold great promise for expanding our ability to treat drug addiction. |
| format | Article |
| id | doaj-art-729f6cb1e75d4c70aae3e31120ffb761 |
| institution | Kabale University |
| issn | 2667-3258 |
| language | English |
| publishDate | 2024-11-01 |
| publisher | KeAi Communications Co. Ltd. |
| record_format | Article |
| series | Fundamental Research |
| spelling | doaj-art-729f6cb1e75d4c70aae3e31120ffb7612024-12-01T05:08:46ZengKeAi Communications Co. Ltd.Fundamental Research2667-32582024-11-014613981400Non-small-molecule therapeutics for drug addiction: From pharmaco-kinetics modulating to synthetic biologyYuanpeng Li0Yibo Wang1Lin Lu2Jie Shi3Xiaohui Wang4Laboratory of Chemical Biology, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun 130022, China; School of Applied Chemistry and Engineering, University of Science and Technology of China, Hefei 230026, ChinaLaboratory of Chemical Biology, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun 130022, ChinaInstitute of Mental Health, Peking University Sixth Hospital and National Clinical Research Center for Mental Disorders, Peking University, Beijing 100191, China; Peking-Tsinghua Center for Life Sciences, Peking University, Beijing 100191, China; International Data Group/McGovern Institute for Brain Research at Peking University, Peking University, Beijing 100191, ChinaNational Institute on Drug Dependence and Beijing Key Laboratory of Drug Dependence, Peking University, Beijing 100191, China; Corresponding authors.Laboratory of Chemical Biology, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun 130022, China; School of Applied Chemistry and Engineering, University of Science and Technology of China, Hefei 230026, China; Beijing National Laboratory for Molecular Sciences, Beijing 100190, China; Corresponding authors.Drug addiction is a pervasive problem worldwide. It not only affects the abuser's life, but also poses a serious threat to public health. Accordingly, there is a strong demand for the development of novel and effective therapies for drug addiction. Considering that small-molecule drugs have only had limited success, there is great interest in developing alternative strategies that extend the reach of small-molecule-based therapies. The antibody-based trapping approach and the enzyme catalytic strategy have been considered as promising ways to reduce the euphoria of drug users by altering drug pharmacokinetics and decreasing drug concentrations in the central nervous system. However, these biological macromolecules are generally unstable and their in vivo half-lives are short. With the rapid development of gene editing technologies, it is possible to perform ex vivo gene therapy for the long-term and stable delivery of enzymes and other effector proteins, which could free abusers from frequent injections of therapeutics. By constructing programmed gene switches that regulate spatiotemporal gene expression in response to illicit drugs, this perspective proposed the concept of preventing drug addiction by the drug itself. This strategy enables the controlled release of therapeutic proteins in vivo and is expected to improve patient safety and compliance. This will open up new opportunities for next-generation medicine and hold great promise for expanding our ability to treat drug addiction.http://www.sciencedirect.com/science/article/pii/S2667325822004137Drug abuseEnzymatic degradationGene therapySynthetic biologyPharmacokinetics |
| spellingShingle | Yuanpeng Li Yibo Wang Lin Lu Jie Shi Xiaohui Wang Non-small-molecule therapeutics for drug addiction: From pharmaco-kinetics modulating to synthetic biology Fundamental Research Drug abuse Enzymatic degradation Gene therapy Synthetic biology Pharmacokinetics |
| title | Non-small-molecule therapeutics for drug addiction: From pharmaco-kinetics modulating to synthetic biology |
| title_full | Non-small-molecule therapeutics for drug addiction: From pharmaco-kinetics modulating to synthetic biology |
| title_fullStr | Non-small-molecule therapeutics for drug addiction: From pharmaco-kinetics modulating to synthetic biology |
| title_full_unstemmed | Non-small-molecule therapeutics for drug addiction: From pharmaco-kinetics modulating to synthetic biology |
| title_short | Non-small-molecule therapeutics for drug addiction: From pharmaco-kinetics modulating to synthetic biology |
| title_sort | non small molecule therapeutics for drug addiction from pharmaco kinetics modulating to synthetic biology |
| topic | Drug abuse Enzymatic degradation Gene therapy Synthetic biology Pharmacokinetics |
| url | http://www.sciencedirect.com/science/article/pii/S2667325822004137 |
| work_keys_str_mv | AT yuanpengli nonsmallmoleculetherapeuticsfordrugaddictionfrompharmacokineticsmodulatingtosyntheticbiology AT yibowang nonsmallmoleculetherapeuticsfordrugaddictionfrompharmacokineticsmodulatingtosyntheticbiology AT linlu nonsmallmoleculetherapeuticsfordrugaddictionfrompharmacokineticsmodulatingtosyntheticbiology AT jieshi nonsmallmoleculetherapeuticsfordrugaddictionfrompharmacokineticsmodulatingtosyntheticbiology AT xiaohuiwang nonsmallmoleculetherapeuticsfordrugaddictionfrompharmacokineticsmodulatingtosyntheticbiology |